Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in Oral Squamous Cell Carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 14, Issue 7, 2009, Pages

  Sappayatosok, Kraisorn ^a   Maneerat, Yaowapa ^a   Swasdison, Somporn ^b   Viriyavejakul, Parnpen ^a   Dhanuthai, Kittipong ^b   Zwang, Julien ^c   Chaisri, Urai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

Author keywords

Angiogenesis; COX 2; Inflammation induced cancer; iNOS; Oral; Squamous cell carcinoma; VEGF

Indexed keywords

CD31 ANTIGEN; CYCLOOXYGENASE 2; FORMALDEHYDE; INDUCIBLE NITRIC OXIDE SYNTHASE; PARAFFIN; POLYCLONAL ANTIBODY; PROTEIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER THERAPY; CARCINOGENESIS; CERVICAL LYMPH NODE; CLINICAL RESEARCH; CONTROLLED STUDY; CORRELATIONAL STUDY; DATA BASE; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PATHOLOGY; PROTEIN EXPRESSION; SAMPLE; STAINING; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE II; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68049106111     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. McKenna PG. Genetics and cancer - a review. Ir Med J. 1983;76:359-363
2. Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys. 2003;417:3-11.
3. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia. 2001;3:53-61.
4. Park SW, Lee SG, Song SH, Heo DS, Park BJ, Lee DW, et al. The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int J Cancer. 2003;107:729-738
5. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 2000;19:19-27.
6. Gallo O, Fabbroni V, Sardi I, Magnelli L, Boddi V, Franchi A. Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas. Biochem Biophys Res Commun. 2002;299:517-524
7. Han M, Wen JK, Zheng B, Zhang DQ. Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sci. 2004;75:675-684
8. Cahlin C, Gelin J, Delbro D, Lönnroth C, Doi C, Lundholm K. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res. 2000;60:1742-1749
9. Brennan PA, Umar T, Wilson AW, Mellor TK. Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia. J Oral Maxillofac Surg. 2002;60:1455-1460
10. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
11. Ekmekcioglu S, Ellerhorst JA, Mumm JB, Zheng M, Broemeling L, Prieto VG, et al. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. Mol Cancer Ther. 2003;2:9-17.
12. Thomsen LL, Miles DW. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev. 1998;17:107-118
13. Nozoe T, Yasuda M, Honda M, Inutsuka S, Korenaga D. Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma. Oncol Rep. 2002;9:521-524
14. Co̧kun U, Günel N, Sancak B, Günel U, Onuk E, Bayram O, et al. Significance of serum vascular endothelial growth factor, insulin- like growth factor-I levels and nitric oxide activity in breast cancer patients. Breast. 2003;12:104-110
15. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst. 1998;90:587-596
16. Dembinska-Kiec A, Dulak J, Partyka L, Huk I, Mailnski T. VEGF-nitric oxide reciprocal regulation. Nat Med. 1997;3:1177.
17. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997;99:2625-2634
18. Shang ZJ, Li ZB, Li JR. VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies. Int J Oral Maxillofac Surg. 2006;35:533-538
19. Baillie R, Harada K, Carlile J, Macluskey M, Schor SL, Schor AM. Expression of vascular endothelial growth factor in normal and tumour oral tissues assessed with different antibodies. Histochem J. 2001;33:287-294
20. Li X, Aase K, Li H, Von Euler G, Eriksson U. Isoform-specific expression of VEGF-B in normal tissues and tumors. Growth Factors. 2001;19:49-59.
21. Shibata M, Kodani I, Osaki M, Araki K, Adachi H, Ryoke K, et al. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol. 2005;41:304-312